Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Merli

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Mycoses|August 19, 2020
Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy studyValeria Cento, Claudia Alteri, Valentina Mancini, et al.
Plos One|November 20, 2020
Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, ItalyValeria Cento, Claudia Alteri, Marco Merli, et al.
The European Journal of Neuroscience|February 24, 2021
Neurological manifestations in patients hospitalized with COVID-19: A retrospective analysis from a large cohort in Northern ItalyGiovanna Travi, Roberto Rossotti, Marco Merli, et al.
Mayo Clinic Proceedings|November 5, 2021
Results of the RENAISSANCE Study: REsponse to BNT162b2 COVID-19 vacciNe-short- And long-term Immune reSponSe evAluatioN in health Care workErsArianna Pani, Valeria Cento, Chiara Vismara, et al.
Infectious Disease Reports|March 24, 2025
Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 InfectionGiovanna Travi, Francesco Peracchi, Marco Merli, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2024
Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort studyAntonio Vena, Michela Schenone, Silvia Corcione, et al.
Frontiers in Immunology|June 20, 2022
Antibody Response to COVID-19 Booster Vaccination in Healthcare WorkersArianna Pani, Alessandra Romandini, Alice Schianchi, et al.
Plos One|September 8, 2020
Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patientsClaudia Alteri, Valeria Cento, Maria Antonello, et al.
Infection|July 28, 2025
Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infectionsNicholas Geremia, Federico Giovagnorio, Antonio Vena, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 24, 2020
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre studyMichele Bartoletti, Lorenzo Marconi, Luigia Scudeller, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Mycoses|August 19, 2020
Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy studyValeria Cento, Claudia Alteri, Valentina Mancini, et al.
Plos One|November 20, 2020
Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, ItalyValeria Cento, Claudia Alteri, Marco Merli, et al.
The European Journal of Neuroscience|February 24, 2021
Neurological manifestations in patients hospitalized with COVID-19: A retrospective analysis from a large cohort in Northern ItalyGiovanna Travi, Roberto Rossotti, Marco Merli, et al.
Mayo Clinic Proceedings|November 5, 2021
Results of the RENAISSANCE Study: REsponse to BNT162b2 COVID-19 vacciNe-short- And long-term Immune reSponSe evAluatioN in health Care workErsArianna Pani, Valeria Cento, Chiara Vismara, et al.
Infectious Disease Reports|March 24, 2025
Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 InfectionGiovanna Travi, Francesco Peracchi, Marco Merli, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2024
Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort studyAntonio Vena, Michela Schenone, Silvia Corcione, et al.
Frontiers in Immunology|June 20, 2022
Antibody Response to COVID-19 Booster Vaccination in Healthcare WorkersArianna Pani, Alessandra Romandini, Alice Schianchi, et al.
Plos One|September 8, 2020
Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patientsClaudia Alteri, Valeria Cento, Maria Antonello, et al.
Infection|July 28, 2025
Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infectionsNicholas Geremia, Federico Giovagnorio, Antonio Vena, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 24, 2020
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre studyMichele Bartoletti, Lorenzo Marconi, Luigia Scudeller, et al.
Pageof 9